340B Drug Pricing Program
Testimony for House Committee on Energy and Commerce Subcommittee on Oversight and Investigations, October 11, 2017.
Testimony of Dr. Charles Daniels House Energy and Commerce Committee 340B Oversight Hearing, July 11, 2018.
The AHA is deeply disappointed in certain proposals that CMS has chosen to set forth in this proposed rule for the CY 2019 outpatient prospective payment system (OPPS), which run afoul of the law and rely on the most cursory of analyses and policy rationales. Taken together, they would have a…
Leaders from the AHA and individual 340B hospitals today came together to announce new principles for ensuring good stewardship of the 340B program. The new AHA-led initiative seeks to strengthen the 340B program by increasing transparency while helping 340B hospitals better publicly communicate…
Today, leaders from the American Hospital Association (AHA) and individual 340B hospitals announced new principles for ensuring good stewardship of the 340B program.
This template provides hospitals with an easy way to estimate savings the 340B hospital derives from participating in the 340B program.
This template provides hospitals with an easy way to share their mission and community served and the impact if the 340B program is scaled back.
To ensure good stewardship of the 340B program, hospitals participating in the program should structure hospital policies and practices to demonstrate their commitment. That demonstration of commitment includes sharing publicly how 340B savings are used to benefit the community, by, for example…
The AHA, Association of American Medical Colleges, America’s Essential Hospitals, 340B Health and three hospital systems today asked a federal court to order the Department of Health and Human Services to make effective within 30 days a final rule requiring drug companies to disclose the ceiling…